Neuroendocrine Carcinoma Treatment Market Poised for 8.1% CAGR Growth Through 2031

The global neuroendocrine carcinoma treatment market is projected to reach $4.2 billion by 2031, rising from $1.97 billion in 2025, with a CAGR of 8.1% during the forecast period from 2025 to 2031.11